Health Alert:

Coronavirus Information: Vaccinations | Testing | Safety Policies & Visitor Guidelines | Appointments & Scheduling | FAQs

Image of the brain demonstrating gadolinium-enhancing lesions typical of MS

Ofatumumab for Relapsing Multiple Sclerosis

March 18, 2021

The Multiple Sclerosis and Related Disorders Center at Penn Medicine is among the 1st in the region to offer the monoclonal antibody Kesimpta® (ofatumumab) for the treatment of adults with relapsing multiple sclerosis (MS).



Share This Page: